Berberine chloride hydrate

Berberine chloride hydrate is an inhibitor of BCL-2 and PARP used in studies of MAPK / ERK Signaling and DNA Damage Response and related signaling programs. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint activation, DNA repair, and genome-stability control in apoptosis, autophagy, and cancer models.

By inhibiting BCL-2 and PARP, Berberine chloride hydrate can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint activation, DNA repair, and genome-stability control. This context is compatible with phosphorylation mapping, pathway-response, and growth assays and DNA-repair, checkpoint, and genotoxic-stress assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, autophagy, and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving BCL-2 and PARP
• Pathway perturbation studies connected to MAPK / ERK Signaling and DNA Damage Response and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in apoptosis, autophagy, and cancer models

Overall, Berberine chloride hydrate is appropriate when a defined chemical perturbant is needed to connect BCL-2 and PARP with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, autophagy, and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.